Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis-Reference-Cited by-同舟云学术

Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Published:2020-08-31 Issue:9 Volume:18 Page:2126-2137
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Zuily Stéphane¹²^ORCID,Cohen Hannah³⁴^ORCID,Isenberg David⁵^ORCID,Woller Scott C.⁶⁷^ORCID,Crowther Mark⁸^ORCID,Dufrost Virginie¹²^ORCID,Wahl Denis¹²^ORCID,Doré Caroline J.⁹^ORCID,Cuker Adam¹⁰^ORCID,Carrier Marc¹¹,Pengo Vittorio¹²^ORCID,Devreese Katrien M.J.¹³^ORCID

Affiliation:

1. Division of Vascular Medicine and Regional Competence Centre for Rare Vascular and Systemic Autoimmune Diseases Nancy Academic Hospital Nancy France

2. Inserm UMR_S 1116 Lorraine University Nancy France

3. Department of Haematology University College London Hospitals NHS Foundation Trust London UK

4. Haemostasis Research Unit, Department of Haematology University College London London UK

5. Centre for Rheumatology, Division of Medicine University College London London UK

6. Department of Medicine Intermountain Medical Center Murray UT USA

7. Department of Internal Medicine University of Utah Salt Lake City UT USA

8. Department of Medicine McMaster University Hamilton Ontario Canada

9. Comprehensive Clinical Trials Unit University College London London UK

10. Perelman School of Medicine University of Pennsylvania Philadelphia PA USA

11. Department of Medicine Ottawa Hospital Research Institute at the University of Ottawa Ottawa Ontario Canada

12. Cardiology Clinic Department of Cardiac‐Thoracic and Vascular Sciences University of Padua Padua Italy

13. Coagulation Laboratory Department of Diagnostic Sciences Ghent University Hospital Ghent Belgium

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.14935

Reference54 articles.

1. Evidence-Based Management of Anticoagulant Therapy

2. Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

3. CrowtherM LegaultKJ GarciaDA et al.Antiphospholipid syndrome. Current Research Highlights and Clinical Insights. Prevention and Treatment of Thrombotic Antiphospholipid Syndrome. Page 223–233. Editor: Springer Nature. 2017.

4. EULAR recommendations for the management of antiphospholipid syndrome in adults

5. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent thrombotic events in pediatric antiphospholipid syndrome: A systematic review and meta-analysis;Thrombosis Research;2024-10

2. Impact of thrombophilia on venous thromboembolism management;La Presse Médicale;2024-09

3. Thrombotic antiphospholipid syndrome: From guidelines to clinical management;Medicina Clínica;2024-08

4. Dual direct oral anticoagulant therapy in challenging thrombosis: a case series;Research and Practice in Thrombosis and Haemostasis;2024-08

5. Rivaroxaban for stroke patients with antiphospholipid syndrome (RISAPS): protocol for a randomized controlled, phase IIb proof-of-principle trial;Research and Practice in Thrombosis and Haemostasis;2024-07